Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Genetic Insights for Drug Development in NAFLD
HTML
Details
Locations
Year:
2019
Type:
review
Source:
Trends in Pharmacological Sciences
DOI:
10.1016/j.tips.2019.05.002
Authors:
Mohammed Eslam,
Jacob George
Institutions:
The University of Sydney,
Westmead Hospital,
Westmead Institute for Medical Research
Language:
English
Topic:
Liver Disease Diagnosis and Treatment
Subfield:
Hepatology
Field:
Medicine
Domain:
Health Sciences
Keywords:
non-alcoholic fatty liver disease,
drug development,
drug target prioritization,
genetic architecture,
pharmacogenomics,
drug discovery,
pharmacotherapy
show all 7
SDG:
Good health and well-being
Open Access status:
closed
Funder:
National Health and Medical Research Council
Awards:
G5537791738,
MERTK receptor tyrosine kinase: A novel therapeutic target for liver fibrosis,
Hepatitis C infection and disease,
How does dietary cholesterol induce non-alcoholic steatohepatitis?
OpenAlex ID:
W2947257201
FWCI:
1.197
Cites:
106
Cited by:
71
Related to:
9